Beyond’s Zhuhai laboratory facilities also attest to its strength in technology by having at its disposal high-precision analysis facilities, such as transmission electron microscopy with a resolution of 0.1nm, as well as automated experiment systems. Taking the material research and development lab as an illustration, the precision error of its nanoscale 3D printing machine is controlled at ±0.05μm (ISO/ASTM 52920 standards), enabling the quick prototyping of complex materials such as titanium alloys and ceramics, and the research and development phase is 60% less compared to traditional procedures. According to the figures in 2023, the lab’s research and development investment accounted for 18% of the income, higher than the industry level of 12%, and built the first full-process AI-based drug screening platform in China, with a 92% prediction accuracy (75% by the traditional method), reducing the new drug development cost by 35%.
For semiconductor testing purposes, Beyond Zhuhai contains a 12-inch wafer probe table (accuracy ±0.1μm) within its clean lab (Class 100), and leakage current of chips manufactured through the 5nm process (threshold ≤1pA) can be detected, and the rate of missed detection is reduced from the industry norm of 0.5% to 0.03%. The TSMC cooperation example shows that the quantum dot laser detection and packaging technology realized by it has increased the yield rate to 99.99%, reducing more than 260 million yuan of wafer scrap loss every year. The lab also introduced the world’s first multi-physics coupled test system (test temperature -196 ° C to 300 ° C) for supporting the end performance verification of third-generation semiconductor materials such as SiC at high pressure (10kV) and high temperature (250 ° C).
The path-breaking work by the biomedical laboratory reiterates its path-breaking status. Beyond’s Organ-on-a-Chip technology replicates the metabolic activity of the liver through microfluid technology (precision ±0.1μL/min for controlling flow rate), and the toxic test result-to-live testing correlation is up to 0.97 (FDA approved criterion ≥0.85). The preclinical development life cycle of new drugs is reduced from 18 months to 6 months. In 2022, the platform will help a multinational pharmaceutical company increase the success rate of liver cancer targeted drug R&D by 40% and save $120 million in project costs. In addition, its CRISPR gene-editing tool has an off-target efficiency of only 0.01% (industry average: 0.5%) and has received 14 global PCT patents.
The Intelligent Manufacturing Laboratory simplifies production lines through Industrial Internet of Things (IIoT) and digital twin technology. The battery pack detection system using Zhuhai Beyond’s products in a company specializing in new energy vehicles uses vision sensors with ±0.02mm precision and AI algorithm to increase cell welding defects detection rate to 99.98%, increase production line efficiency by 30%, and lower costs of quality checks by 80 million yuan a year. Its domestically developed 5G+ edge computing system (<2ms latency) has been implemented on 30 production lines, increasing overall equipment efficiency (OEE) from 78% to 93%.
Market leadership is also supported by industry certifications and partnership. Outside labs in Zhuhai have been accredited by CNAS (ISO/IEC 17025), FDA GLP and EU EMC Directive 2014/30/EU, and been involved in the development of seven national industry standards by 2023. The research and development project with Huawei on quantum computing materials has been successful in extending the superconducting qubit coherence time to 500μs (the global average is 300μs), and enhancing the performance of quantum computers by 66%. According to the Frost & Sullivan report, its R&D center total capacity ranks in the top 5% in the Asia-Pacific region, and its technological success conversion rate as high as 82% (industry average 55%).
Zhuhai Beyond pioneer design is also available in the area of green energy. The firm has achieved a 5.2W/cm² (industry benchmark 4.5W/cm²) single cell power density and life cycle test over 30,000 hours (DOE target 25,000 hours) megawatt hydrogen fuel cell test platform. In 2024, the platform is the foundation for a core enterprise to validate the world’s first hydrogen-powered freighter to reduce 18% hydrogen consumption and 42% carbon emission.
From investment intensity in R&D (18%) to technical specifications (e.g., 0.1nm resolution) and industrial influence (7 national standards) to commercialization achievements (30,000 hours of hydrogen battery lifespan), Beyond’s laboratory equipment in Zhuhai has reaffirmed its global top-level technical capabilities in many ways, and continued to lead high-end and intelligent upgrading of the industrial chain.
